Guardant Health

YTD

ALL

Trade Guardant Health 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About GH

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection.

CEO

Helmy Eltoukhy

CEOHelmy Eltoukhy

Employees

2,021

Employees2,021

Headquarters

Palo Alto, California

HeadquartersPalo Alto, California

Founded

2011

Founded2011

Employees

2,021

Employees2,021

GH Key Statistics

Market cap

14.04B

Market cap14.04B

Price-Earnings ratio

-33.78

Price-Earnings ratio-33.78

Dividend yield

—

Dividend yield—

Average volume

2.36M

Average volume2.36M

High today

$109.59

High today$109.59

Low today

$105.03

Low today$105.03

Open price

$106.01

Open price$106.01

Volume

1.89M

Volume1.89M

52 Week high

$112.43

52 Week high$112.43

52 Week low

$29.91

52 Week low$29.91

Stock Snapshot

The current Guardant Health(GH) stock price is $108.52, with a market capitalization of 14.04B. The stock trades at a price-to-earnings (P/E) ratio of -33.78.

As of 2025-12-04, Guardant Health(GH) stock has fluctuated between $105.03 and $109.59. The current price stands at $108.52, placing the stock +3.3% above today's low and -1.0% off the high.

Guardant Health(GH) shares are trading with a volume of 1.89M, against a daily average of 2.36M.

During the past year, Guardant Health(GH) stock moved between $29.91 at its lowest and $112.43 at its peak.

Analyst ratings

88%

of 26 ratings

Buy

88.5%

Hold

7.7%

Sell

3.8%

People also own

Based on the portfolios of people who own GH. This list is generated using Robinhood data, and it’s not a recommendation.